BioCryst Pharmaceuticals | BCRX - Trade Debtors

Stock Price
9.50
Daily Change
-0.02 -0.21%
Monthly
3.71%
Yearly
26.16%
Q2 Forecast
9.29

BioCryst Pharmaceuticals reported $106.82M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
BioCryst Pharmaceuticals USD 106.82M 15.49M Dec/2025
Chugai Pharma JPY 443.11B 89.26B Dec/2025
Daiichi Sankyo JPY 695.95B 79.1B Dec/2025
DBV Technologies USD 15.97M 279K Sep/2025
Enanta Pharmaceuticals USD 40.16M 1.52M Dec/2024
Gilead Sciences USD 4.91B 182M Dec/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Glaxosmithkline GBP 10.45B 707.81M Dec/2025
Incyte USD 1.02B 128.52M Dec/2025
Ionis Pharmaceuticals USD 66M 41.39M Dec/2025
Karyopharm Therapeutics USD 26.18M 5.6M Dec/2025
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
Novavax USD 106.45M 72.27M Dec/2025
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025